Analgesic, Anesthetic and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) (U01)
This award is intended to provide support for developing and maintaining an organizational infrastructure to support a broad-based public-private partnership under FDA's Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) Initiative.
Specific projects under the ACTTION Initiative may also be funded.
Specific projects under the ACTTION Initiative may also be funded.
Who's Eligible
Obtain Full Opportunity Text:
Full Announcement of RFA-FD-16-047
Additional Information of Eligibility:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.
Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.
Full Opportunity Web Address:
Contact:
Agency Email Description:
Agency Email:
eric.bozoian@fda.hhs.gov
Date Posted:
2016-04-19
Application Due Date:
2016-06-20
Archive Date:
2016-07-20
Social Entrepreneurship
Spotlight
Social Enterprises: Key to Enhancing a Nation’s Health
Glasgow Caledonian University (GCU) has launched a series of noteworthy research projects to learn if social enterprises can help Scotland lose its “sick man of Europe” label and boost the nation’s overall health.
Learn How to Identify and Avoid Grant Scams
